Accessibility settings

This paper is in the following e-collection/theme issue:

Infectious Diseases (non-STD/STI) (1906) Longitudinal and Cohort Studies in Public Health (887) Theme Issue: Novel Coronavirus (COVID-19) Outbreak Rapid Reports (2028) Hygiene and Infection Prevention (430) Outbreak and Pandemic Preparedness and Management (1954)

Published on in Vol 12 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/92002, first published .
Serial COVID-19 antigen rapid tests on a table with a mask and swab.

Characteristics Influencing Adherence to SARS-CoV-2 Serial Antigen Testing Following a Federal Safety Communication: Cohort Study

Characteristics Influencing Adherence to SARS-CoV-2 Serial Antigen Testing Following a Federal Safety Communication: Cohort Study

Authors of this article:

Micajah Z McGarity1 Author Orcid Image ;   Catherine C Pollack1 Author Orcid Image ;   Elizabeth A Currier1 Author Orcid Image ;   Andrew C Godoshian2 Author Orcid Image ;   Zachary R Smith2, 3 Author Orcid Image ;   Marcus Siddall2 Author Orcid Image ;   Gregg M Tavolacci4 Author Orcid Image ;   Reynolds M Salerno5 Author Orcid Image ;   Thomas C Tsai6 Author Orcid Image ;   Michael F Iademarco7 Author Orcid Image ;   Joseph D Miller2 Author Orcid Image
Article Authors Cited by Tweetations Metrics

Micajah Z McGarity   1 * , MSE, PhD ;   Catherine C Pollack   1 * , PhD ;   Elizabeth A Currier   1 , MPH, MBA ;   Andrew C Godoshian   2 , MPH ;   Zachary R Smith   2, 3 , PhD ;   Marcus Siddall   2 , PhD ;   Gregg M Tavolacci   4 , BS ;   Reynolds M Salerno   5 , PhD ;   Thomas C Tsai   6 , MD, MPH ;   Michael F Iademarco   7 * , MD, MPH ;   Joseph D Miller   2 , MBA, PhD

1 Johns Hopkins University Applied Physics Laboratory, Laurel, MD, United States

2 Increasing Community Access to Testing, Treatment, and Response Program, Centers for Disease Control and Prevention, Atlanta, GA, United States

3 Walgreens Co, Deerfield, IL, United States

4 eTrueNorth, Fort Worth, TX, United States

5 Office of Laboratory Systems and Response, Centers for Disease Control and Prevention, Atlanta, GA, United States

6 Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, United States

7 (retired), United States Public Health Service, Washington, DC, United States

*these authors contributed equally

Corresponding Author:

  • Joseph D Miller, MBA, PhD
  • Increasing Community Access to Testing, Treatment, and Response Program
  • Centers for Disease Control and Prevention
  • 1600 Clifton Rd NE
  • Atlanta, GA 30329
  • United States
  • Phone: 1 404-645-3355
  • Email: faz9@cdc.gov